Literature DB >> 4639942

Comparative study of macrodantin and pyridium in controlling morbidity following surgery of the lower urinary tract.

J C Charles, G W Jones.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4639942      PMCID: PMC2608948     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  9 in total

1.  PREVENTION OF EPIDIDYMITIS AFTER PROSTATECTOMY BY PROPHYLACTIC ANTIBIOTICS AND PARTIAL VASECTOMY.

Authors:  J F REEVES; R SCOTT; F B SCOTT
Journal:  J Urol       Date:  1964-11       Impact factor: 7.450

2.  PROSTATECTOMY AND INFECTION.

Authors:  A W BRUCE; J QUIRK
Journal:  J Urol       Date:  1964-11       Impact factor: 7.450

3.  NEG GRAM AND FURADANTIN IN THE TREATMENT OF INJECTION FOLLOWING TRANSURETHRAL PROSTATECTOMY.

Authors:  P O MADSEN; M H CHANEY; E M LAPINSKI
Journal:  Acta Chir Scand       Date:  1965-06

4.  Postoperative infection in urology.

Authors:  A MILLER; W A GILLESPIE; K B LINTON; N SLADE; J P MITCHELL
Journal:  Lancet       Date:  1958-09-20       Impact factor: 79.321

5.  Effect of nitrofurantoin on bacteruria of infection following prostatic operation.

Authors:  J W DRAPER; R ZUFALL; L T ROSENBERG; V KNIGHT
Journal:  J Urol       Date:  1954-12       Impact factor: 7.450

6.  The prophylactic use of chloramphenicol in transurethral resections of the prostate gland.

Authors:  D M APPLETON; B A WAISBREN
Journal:  J Urol       Date:  1956-02       Impact factor: 7.450

7.  Antibiotic prophylaxis in transurethral prostatic resection: a clinical study.

Authors:  H B SIMON; M T JEREMIAS; L F GREENE; J E GERACI
Journal:  J Urol       Date:  1955-07       Impact factor: 7.450

8.  Routine use of antibiotics in transurethral prostatic resection; a clinical investigation.

Authors:  C D CREEVY; M J FEENEY
Journal:  J Urol       Date:  1954-05       Impact factor: 7.450

9.  Epidemiologic aspects of postoperative sepsis in a urologic practice (with a note concerning antibacterial prophylaxis).

Authors:  F M Wilson; E J Shumaker; V Fentress; A M Lerner
Journal:  J Urol       Date:  1971-02       Impact factor: 7.450

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.